AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11131366 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with 1.7 g of EPA plus 1.15 g of DHA/day (as Maxepa capsules) for 28 days
Number of subjects: 35
Study 11131366 — intervention group
Group type: COMPARATOR
Intervention: Wash-out control period with 21 patients
Number of subjects: 35
Study 11131366 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with Maxepa capsules
Number of subjects: 35
Study 11131366 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall n-6 FA reduction
Number of subjects: 35
Study 8894152 — intervention group
Group type: EXPERIMENTAL
Intervention: Papers published in BJO
Number of subjects: 475
Study 8894152 — intervention group
Group type: COMPARATOR
Intervention: Papers published in EJO
Number of subjects: 475
Study 8894152 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 475
Study 1727236 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg per day)
Number of subjects: 194
Study 1727236 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (mean daily dose, 0.4 mg per kilogram of body weight in successful treatment; 0.5 mg per kilogram in treatment failure)
Number of subjects: 194
Study 1727236 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality due to cryptococcosis
Number of subjects: 194
Study 1727236 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to first negative cerebrospinal fluid culture
Number of subjects: 194
Study 6693782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidarabine for seven days
Number of subjects: 85
Study 6693782 — intervention group
Group type: COMPARATOR
Intervention: Placebo for seven days
Number of subjects: 85
Study 6693782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidarabine for seven days (Group A)
Number of subjects: 85
Study 31264183 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week physical activity module with Fitbit trackers
Number of subjects: 50
Study 31264183 — intervention group
Group type: COMPARATOR
Intervention: Care plan alone (comparison group)
Number of subjects: 50
Study 29880436 — intervention group
Group type: EXPERIMENTAL
Intervention: Height categorized into groups (≤ 165 cm, 166-175 cm, 176-185 cm, ≥ 186 cm for males; ≤ 154 cm, 155-164 cm, 165-174 cm, ≥ 175 cm for females)
Number of subjects: 695
Study 29880436 — intervention group
Group type: EXPERIMENTAL
Intervention: Height as a continuous variable
Number of subjects: 695
Study 27009617 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 333
Study 27009617 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg daily
Number of subjects: 333
Study 27009617 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 225 mg daily
Number of subjects: 333
Study 27009617 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 300 mg daily
Number of subjects: 333
Study 25160734 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy (IOERT) using electrons
Number of subjects: 0
Study 25160734 — intervention group
Group type: COMPARATOR
Intervention: External beam radiation therapy (EBRT)
Number of subjects: 0
Study 25160734 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy (IORT) using 50-kV X-rays
Number of subjects: 0
Study 22235820 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (n=8898)
Number of subjects: 32804
Study 22235820 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril (n=8904)
Number of subjects: 32804
Study 19224415 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple in situ decompression of the ulnar nerve in the cubital tunnel (open or endoscopic technique under local anesthesia)
Number of subjects: 0
Study 19224415 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar transposition of the ulnar nerve (subcutaneous or submuscular technique)
Number of subjects: 0
Study 19224415 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (prevention of exposure to external noxes)
Number of subjects: 0
Study 17470723 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 479
Study 17470723 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE‐I
Number of subjects: 479
Study 15523953 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided customized ablation (Group 2)
Number of subjects: 24
Study 15523953 — intervention group
Group type: COMPARATOR
Intervention: Conventional LASIK (Group 1)
Number of subjects: 24
Study 11376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographically and stereotactically guided fine-needle aspiration biopsy (FNAB)
Number of subjects: 442
Study 11376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographically guided FNAB
Number of subjects: 442
Study 11376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactically guided FNAB
Number of subjects: 442
Study 11376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of masses with FNAB
Number of subjects: 442
Study 11376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of calcifications with FNAB
Number of subjects: 442
Study 11376270 — intervention group
Group type: COMPARATOR
Intervention: Core-needle biopsy and needle-localized open surgical biopsy
Number of subjects: 442
Study 10771928 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine in association with DPT vaccine at different sites
Number of subjects: 110
Study 10771928 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP‐T and DPT both vaccines at the same site mixed in the same syringe
Number of subjects: 110
Study 10771928 — intervention group
Group type: COMPARATOR
Intervention: PRP‐T vaccine
Number of subjects: 110
Study 8290663 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 56
Study 8290663 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 56
Study 2883715 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine 60 mg twice daily
Number of subjects: 42
Study 2883715 — intervention group
Group type: COMPARATOR
Intervention: dexchlorpheniramine 6 mg twice daily
Number of subjects: 42
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Darapladib
Number of subjects: 10634
Study 30897999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Darapladib or Placebo
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density lipoprotein cholesterol
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus requiring treatment
Number of subjects: 10634
Study 30897999 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 10634
Study 27701683 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (30 mg/day)
Number of subjects: 66
Study 27701683 — intervention group
Group type: COMPARATOR
Intervention: Citalopram (40 mg/day)
Number of subjects: 66
Study 26809344 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus text-message reminder
Number of subjects: 3200
Study 26809344 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3200
Study 23942244 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo-aerobic training (PLA-AT)
Number of subjects: 42
Study 23942244 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy-aerobic training (ET-AT)
Number of subjects: 42
Study 23942244 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control
Number of subjects: 42
Study 23942244 — intervention group
Group type: COMPARATOR
Intervention: Estrogen therapy-control
Number of subjects: 42
Study 22769041 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Cognitive Behavioural Therapy (CBT) intervention, which includes principles of recognizing, registering, and altering negative thoughts, augmented with direct in-vivo activation by occupational or movement therapists.
Number of subjects: 106
Study 22769041 — intervention group
Group type: COMPARATOR
Intervention: Computerized cognitive training intervention (Control group).
Number of subjects: 106
Study 22769041 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented CBT intervention.
Number of subjects: 106
Study 19640972 — intervention group
Group type: EXPERIMENTAL
Intervention: High cruciferous vegetable diet (14 g cruciferous vegetables/(kg body weightd))
Number of subjects: 17
Study 19640972 — intervention group
Group type: COMPARATOR
Intervention: Low-phytochemical, low-fiber basal diet
Number of subjects: 17
Study 17466587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed high-frequency electromagnetic field (pulsed EMF) emitted by a mobile phone for thirty minutes
Number of subjects: 10
Study 17466587 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure for thirty minutes
Number of subjects: 10
Study 15955854 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA and brachytherapy
Number of subjects: 199
Study 15955854 — intervention group
Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 199
Study 12670123 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen at 2 atm abs (HBO2)
Number of subjects: 5
Study 12670123 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased atmospheric pressure (10.5% oxygen at 2 atm abs)
Number of subjects: 5
Study 12670123 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 5
Study 12670123 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxia (100% oxygen)
Number of subjects: 5
Study 10379619 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (5, 10, 20 mg/70 kg)
Number of subjects: 18
Study 10379619 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.125, 0.25, 0.5 mg/70 kg)
Number of subjects: 18
Study 8537264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin, 500 mg once daily for 5 days
Number of subjects: 191
Study 8537264 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin, 250 mg twice daily for 7 days
Number of subjects: 191
Study 1665118 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (FLN)
Number of subjects: 0
Study 1665118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6119872 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 19
Study 6119872 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg)
Number of subjects: 19
Study 6119872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31743793 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet emphasizing minimally-processed whole foods from plants
Number of subjects: 0
Study 31743793 — intervention group
Group type: COMPARATOR
Intervention: Low-fat omnivorous diet
Number of subjects: 0
Study 30621476 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 80
Study 30621476 — intervention group
Group type: COMPARATOR
Intervention: Conventional energy-restricted diet (C)
Number of subjects: 80
Study 28818674 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) administered 24 hours prior to surgery
Number of subjects: 40
Study 28818674 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 40
Study 28818674 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 40
Study 26428278 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm date consumption (seven dates, approximately 50 g)
Number of subjects: 22
Study 26428278 — intervention group
Group type: COMPARATOR
Intervention: Control group (maltodextrin‐dextrose, 37·1 g)
Number of subjects: 22
Study 23422397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU 4 times per day)
Number of subjects: 45
Study 23422397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 21287538 — intervention group
Group type: EXPERIMENTAL
Intervention: Boswellia serrata (BS) 4200 mg/day
Number of subjects: 44
Study 21287538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 21287538 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 44
Study 19594003 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive THA (mini‐incision group)
Number of subjects: 53
Study 19594003 — intervention group
Group type: COMPARATOR
Intervention: Conventional THA (conventional incision group)
Number of subjects: 53
Study 19594003 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study 17190867 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 217
Study 17190867 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Number of subjects: 217
Study 15042528 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab plus CHOP
Number of subjects: 399
Study 15042528 — intervention group
Group type: COMPARATOR
Intervention: CHOP alone
Number of subjects: 399
Study 10893915 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding support including anticipatory counseling and monthly clinical follow-up
Number of subjects: 0
Study 10893915 — intervention group
Group type: COMPARATOR
Intervention: Control group (no breastfeeding support)
Number of subjects: 0
Study 10893915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (breastfeeding support)
Number of subjects: 0
Study 9003086 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA flow cytometry
Number of subjects: 30
Study 1342280 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle interventions (weight loss, sodium restriction, stress management)
Number of subjects: 2182
Study 1342280 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition supplements (calcium, magnesium, potassium, fish oil)
Number of subjects: 2182
Study 1342280 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2182
Study 3158327 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% zinc pyrithione shampoo
Number of subjects: 32
Study 3158327 — intervention group
Group type: COMPARATOR
Intervention: Shampoo without zinc pyrithione (placebo)
Number of subjects: 32
Study 3310910 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermabrasion performed six to eight months after grafting
Number of subjects: 192
Study 3310910 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no dermabrasion)
Number of subjects: 192
Study 3310910 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermabrasion
Number of subjects: 192
Study 31535213 — intervention group
Group type: EXPERIMENTAL
Intervention: 136.6 mg isoflavones (as aglycone equivalents)
Number of subjects: 99
Study 31535213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 30466866 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA (2 g per day)
Number of subjects: 709
Study 30466866 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg per day)
Number of subjects: 709
Study 30466866 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA plus Aspirin
Number of subjects: 709
Study 30466866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 709
Study 26830694 — intervention group
Group type: EXPERIMENTAL
Intervention: MCO (multi-criteria optimization)
Number of subjects: 10
Study 25703878 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 837
Study 25703878 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 837
Study 24071754 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT family education program (6 weekly 2 hour sessions)
Number of subjects: 44
Study 24071754 — intervention group
Group type: COMPARATOR
Intervention: Gam-Anon 12-step program
Number of subjects: 44
Study 20160396 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1016
Study 20160396 — intervention group
Group type: COMPARATOR
Intervention: Non-statin treatment
Number of subjects: 1016
Study 17888410 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 IU oxytocin
Number of subjects: 52
Study 17888410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 16632782 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography with a 6.5-MHz micro convex probe
Number of subjects: 100
Study 15156808 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ablation with a bipolar multielectrode 3 mm Covac wand (power 3 setting)
Number of subjects: 16
Study 15156808 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ablation with a bipolar multielectrode 3 mm Covac wand (power setting 7)
Number of subjects: 16
Study 15156808 — intervention group
Group type: COMPARATOR
Intervention: Resection with a motorized 4.5 full‐radius resector
Number of subjects: 16
Study 15156808 — intervention group
Group type: COMPARATOR
Intervention: Resection with a scalpel blade
Number of subjects: 16
Study 10895748 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. ketamine 0.5-0.6 mg kg-1
Number of subjects: 80
Study 10895748 — intervention group
Group type: COMPARATOR
Intervention: i.m. morphine 0.1-0.15 mg kg-1
Number of subjects: 80
Study 10895748 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 8884413 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep/wake cycles and meal-times advanced for two hours (Day 2)
Number of subjects: 8
Study 8884413 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep/wake cycles and meal-times delayed for two hours (Day 3)
Number of subjects: 8
Study 8884413 — intervention group
Group type: COMPARATOR
Intervention: Control days (Days 1 and 4)
Number of subjects: 8
Study 8884413 — intervention group
Group type: EXPERIMENTAL
Intervention: Only sleep/wake cycle advanced for two hours (Day 5)
Number of subjects: 8
Study 1401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoes with thick, soft midsoles
Number of subjects: 25
Study 1401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoes with thick midsoles
Number of subjects: 25
Study 1401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Barefoot
Number of subjects: 25
Study 1401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher comfort shoe types
Number of subjects: 25
Study 1401691 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoes with thin, hard soles
Number of subjects: 25
Study 4076532 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropii bromidum (10 or 20 mg i.v.)
Number of subjects: 160
Study 4076532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 30635696 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 416
Study 30635696 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide
Number of subjects: 416
Study 30635696 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 416
Study 29664851 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed home exercise
Number of subjects: 51
Study 29664851 — intervention group
Group type: COMPARATOR
Intervention: Formal outpatient physical therapy (PT)
Number of subjects: 51
Study 26946990 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 92
Study 26946990 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise
Number of subjects: 92
Study 26946990 — intervention group
Group type: COMPARATOR
Intervention: Light intensity exercise
Number of subjects: 92
Study 26946990 — intervention group
Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 92
Study 24213610 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg)
Number of subjects: 28
Study 24213610 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 28
Study 24213610 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (induced by lowering arterial saturation to 90% and 80%)
Number of subjects: 28
Study 24213610 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercapnia (increased end‐tidal CO2 10 mmHg above baseline)
Number of subjects: 28
Study 23341531 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + TNFerade
Number of subjects: 304
Study 23341531 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 304
Study 20582493 — intervention group
Group type: EXPERIMENTAL
Intervention: T8 floating tablets
Number of subjects: 0
Study 20582493 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release tablets (Vastrel® 20 mg)
Number of subjects: 0
Study 18837755 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching protocol 1
Number of subjects: 75
Study 18837755 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching protocol 2
Number of subjects: 75
Study 18837755 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bleaching)
Number of subjects: 75
Study 16822597 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa-IPV+MMR
Number of subjects: 362
Study 16822597 — intervention group
Group type: COMPARATOR
Intervention: DTPa+IPV+MMR
Number of subjects: 362
Study 14607350 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 19
Study 14607350 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 19
Study 14607350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 10871715 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen trial participants (n=53)
Number of subjects: 106
Study 10871715 — intervention group
Group type: COMPARATOR
Intervention: Women who declined the trial (n=53)
Number of subjects: 106
Study 8959081 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH (Metrodin, 150 units)
Number of subjects: 21
Study 8959081 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 21
Study 1558571 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with epilepsy
Number of subjects: 112